Oscar Tahuahua, Medical Oncology Fellow at the National Cancer Institute of Mexico, shared a post on X:
“1 in 5 patients. No symptoms.
In a prospective study (n=112) of HER2+ and TNBC, brain MRI screening detected metastases in 19.6% (9.8% at baseline) and 2/3 were asymptomatic.
Earlier detection may allow more SRS and less WBRT.
Is it time to rethink brain MRI screening?”
Title: A prospective study for brain metastasis imaging screening in patients with advanced HER2-positive or triple-negative breast cancer
Authors: G.M. Kim, M.H. Kim, H.S. Park, J.H. Kim, K.H. Kim, S.-G. Kim, J.Y. Kim, H.S. Park, S. Park, S.-K. Lee, Y.B. Kim, J.H. Chang, S.I. Kim, J. Sohn
Other articles featuring Oscar Tahuahuaon OncoDaily.
